Bufotalidin
CAS: 465-90-7
Ref. 3D-AAA46590
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- (3Beta,5Beta)-3,5,14-Trihydroxy-19-Oxobufa-20,22-Dienolide
- (3Beta,5Beta,8Xi,9Xi)-3,5,14-Trihydroxy-19-Oxobufa-20,22-Dienolide
- (3β,5β)-3,5,14-Trihydroxy-19-oxobufa-20,22-dienolide
- 19-Oxo-3-beta,5,14-trihydroxy-5-beta-bufa-20,22-dienolide
- 5-beta-Bufa-20,22-dienolide, 3-beta,5,14-trihydroxy-19-oxo-
- 5β-Bufa-20,22-dienolide, 3β,5,14-trihydroxy-19-oxo-
- Brn 0056259
- Bufa-20,22-dienolide, 3,5,14-trihydroxy-19-oxo-, (3beta,5beta)-
- Gellebrigenin
- Hellebrigenin
- Ver mais sinónimos
- Nsc 89594
Bufotalidin is a caffeic acid derivative that has been shown to have inhibitory properties on the heart and locomotor activity. Bufotalidin was shown to decrease the cardiac contractility of isolated rat hearts by inhibiting calcium influx. It also inhibits basic protein kinase C (PKC) in HL-60 cells, which may be due to its ability to inhibit PKC translocation from the cytosol to the membrane. Bufotalidin also has an inhibitory effect on autophagy, which is a process that breaks down cellular components. The molecular mechanisms underlying these effects are not yet understood.
Propriedades químicas
Consulta técnica sobre: 3D-AAA46590 Bufotalidin
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
